ArticlePreventive medicine reports2026
Glucagon-like peptide-1 receptor agonist use and risk of gynecologic cancers: a meta-analysis of multinational real-world cohort studies.
Rongxia Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.